Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and businesses
Imported from official source
Milestone deal secures UK’s medicines access for patients, with a wide range of groundbreaking new treatments to reach NHS front-line quicker.
This version
- Version
- 1 of 1
- Recorded
- September 20, 2026 19:53
- Change
- Initial
- Content hash
52070865c08134c1f2b46afdbbd9bac8- All versions
- Revision history